INNO-GENE SA ZY -10 Cash Flow-to-Debt Ratio
INNO-GENE SA ZY -10 cash flow-to-debt ratio. INNO-GENE SA ZY -10 (WQ3) has a Cash Flow-to-Debt Ratio of 0.01x as of June 2025, meaning its operating cash flow of €54.00K could theoretically repay 0% of its total liabilities (€7.45 Million) in one year. Check INNO-GENE SA ZY -10 cash earnings quality to evaluate the quality of earnings relative to operating cash generation.
CF-to-Debt Ratio
Operating Cash Flow
Total Liabilities
Data as of
Cash Flow-to-Debt Ratio of INNO-GENE SA ZY -10 (2021–2024)
Cash flow-to-debt ratio of INNO-GENE SA ZY -10 from 2021 to 2024. Historical debt coverage capacity for INNO-GENE SA ZY -10 across 4 annual periods. Check how aggressively does INNO-GENE SA ZY -10 reinvest cash to assess the company's total reinvestment commitment from operating cash flow.
INNO-GENE SA ZY -10 Cash Flow-to-Debt Ratio by Year (2021–2024)
INNO-GENE SA ZY -10 cash flow-to-debt ratio by year from 2021 to 2024. Year-by-year debt coverage analysis for INNO-GENE SA ZY -10. For the full cash flow conversion analysis, see cash efficiency ratio of INNO-GENE SA ZY -10.
| Year | CF-to-Debt Ratio | Operating CF (EUR) | Total Liabilities | YoY Change |
|---|---|---|---|---|
| 2024 | -0.17x | €-1.13 Million | €6.50 Million | ▲ +77.9% |
| 2023 | -0.79x | €-2.49 Million | €3.16 Million | ▼ -15993.0% |
| 2022 | 0.00x | €11.00K | €2.22 Million | ▼ -99.6% |
| 2021 | 1.21x | €6.75 Million | €5.60 Million | — |